Vice President and Deputy Chief Clinical Officer for University of Maryland Medical Center
Vice President, Deputy Chief Clinical Officer
Education and Training
1987-1991 Bachelor of Science in Chemistry
University of Michigan, Ann Arbor, MI
1993-1997 Doctor of Medicine
Northwestern University Medical School, Chicago, IL
2000-2004 Doctor of Philosophy in Clinical Investigation
Advisor: Peter J. Pronovost, MD, PhD
Thesis: Optimizing Clinician Practices to Prevent Central
Venous Catheter-Related Bloodstream Infections
in Intensive Care Units
Graduate Training Program in Clinical Investigation
Johns Hopkins Bloomberg School of Public Health, Baltimore, MD
Post-Graduate Education and Training
1997-2000 Residency, Internal Medicine
University of California, San Francisco, San Francisco, CA
2000-2005 Fellowship, Pulmonary and Critical Care Medicine
Johns Hopkins University, Baltimore, MD
2003 Fellow, Center for Civilian Biodefense Strategies
Johns Hopkins University, Baltimore, MD
(Center transitioned from Johns Hopkins to UPMC in 2003)
2003-2005 Fellow, Center for Biosecurity of UPMC
University of Pittsburgh Medical Center, Pittsburgh, PA
Lewis Rubinson, MD, PhD, FCCP is Professor of Medicine in the Program in Trauma at the University of Maryland School of Medicine and Vice President and Deputy Chief Clinical Officer at the University of Maryland Medical Center (UMMC). Dr. Rubinson is also Chairperson for Resusciation and Medical Director for the Rapid Response Team at UMMC. Previously he was the inaugural Director of the CCRU from 2013-2015, and then Assistant Chief Medical Officer for Critical Care at UMMC from 2015-2018.
Dr. Rubinson is a key instituional leader in establishing systems to ensure that deteriorating patients get immediate, high reliable resusciation care and have timely access to critical care and procedural areas. In collaboration with UMMC Rapid Response team members and key disiciplines (pharmacy, respiratory care, anesthesia, medicine and critical care), he is leading the development of a comprehensive resuscitation platform and processes.
Dr. Rubinson is also an international leader in critical care management of severe infections including those due to novel pathogens. He has worked and published extensively on mass critical care preparedness, managing severe contagious respiratory infections during outbreaks, and mass casualty mechanical ventilation. In addition, Dr. Rubinson has been an international proponent and leader for establishing systems and processes to ensure key clinically-relevant questions are answered during evolving public health emergencies. Dr. Rubinson was the Health and Human Services lead for the largest critical care registry established during the 2009 influenza pandemic and he is currently the Co-chairperson of the Protocol Committee for the Discovery- Program in Emergency Preparedness PFDA and BARDA contract for rapid clinical learning during public health emergencies.
Prior to joining the University of Maryland, Dr. Rubinson was the Chief Medical Officer (Acting) of the National Disaster Medical System(NDMS) in the Office of Emergency Management within the Office of the Assistant Secretary for Preparedness and Response in the US Department of Health and Human Services. In that role, and previously as Deputy Chief Medical Officer he had extensive experience with disaster medical cache development and assessment. Dr. Rubinson served as the federal CMO in the HHS Secretary’s Operation Center for major events such as Superstorm Sandy. Lewis also has extensive field experience and has deployed on numerous occasions for NDMS as a front-line clinician and as the medical lead for the Incident Response Coordination Team. Lewis was a clinician consultant for the World Health Organization and the clinical lead at Kenema Government Hospital in Sierra Leone in Sep 2014.
Dr. Rubinson received his medical degree from Northwestern University Medical School and completed residency in Internal Medicine at the University of California San Francisco. He completed a Pulmonary and Critical Care Medicine fellowship at Johns Hopkins University, where he also received a PhD in Clinical Investigation at the Bloomberg School of Public Health.
Ventilation for Severe Respiratory Failure, Resuscitation, Mass Casualty Preparedness and Response, Extracorporeal Life Support, Highly Reliable Healthcare Delivery
- Rubinson L, Nuzzo JB, Talmor D, O’Toole T, Kramer BR, Inglesby TV. Augmentation of hospital critical care capacity after bioterrorist attacks or epidemics: recommendations of the Working Group on Emergency Mass Critical Care. Critical Care Medicine 2005; 33: 2393-2403.
- Rubinson L, Hick J, Curtis JR, Branson R, Burns S, Christian M, Devereaux A, Dichter J , Talmor D, Erstad B, Medina J, Geiling J. Definitive care for the critically ill during a disaster: Medical resources for surge capacity: From a Task Force for Mass Critical Care Summit Meeting, January 26–27, 2007, Chicago, IL. Chest 2008; 133: 32S-50S.
- Daugherty EL, Branson RD, Devereaux A, and Rubinson L. Infection control in mass respiratory failure: Preparing to respond to H1N1. Critical Care Medicine 2010; 38 (4 suppl): e1 103-109.
- Rubinson L, Vaughn F, Nelson S, Giordano S, Kallstrom T, Buckley T, BurneyT, Hupert N, Mutter R, Handrigan M, Yeskey K, Lurie N, Branson R. Mechanical ventilators in US acute care hospitals. Disaster Medicine and Public Health Preparedness 2010; 4: 199-206.
- Rice TW, Rubinson L, Uyeki TM, Vaughn FL, John BB, Miller III RR, Higgs E, Randolph AG, Smoot BE, Thompson BT for the NHLBI ARDS Network. Critical illness from 2009 pandemic influenza A (H1N1) and bacterial co-infection in the United States. Critical Care Medicine 2012; 40: 1487-1498.
- Rubinson L, Mutter R, Viboud C, Hupert N, Uyeki T, Creanga A, Fineli L, Iwashyna T, Carr B, Merchant R, Katikineni, Vaughn F, Clancy C, Lurie N. Impact of the Fall 2009 Influenza A(H1N1)pdm09 Pandemic on US Hospitals. Medical Care 2013; 51: 259-265.
- Murphy DJ, Rubinson L, Blum J, Isakov A, Bhagwanjee S, Cairns CB, Cobb JP, Sevransky J on behalf of the United States Critical Illness and Injury Trials Group – Program for Emergency Preparedness. Development of a core clinical dataset to characterize serious illness, injuries, and resource requirements for acute medical responses to public health emergencies. Critical Care Medicine. 2015; 43: 2403-2408.
- Scalea TM, Rubinson L, Tran Q, Jones KM, Rea JH, Stein DM, Bartlett ST, O’Connor JV. Critical Care Resuscitation Unit: An innovative solution to expedite transfer of patients with time-sensitive critical illness. Journal of American College of Surgeons. 2016; 222: 614-621.
- Leligdowicz A, Fischer WA 2nd, Uyeki TM, Fletcher TE, Adhikari NK, Portella G, Lamontagne F, Clement C, Jacob ST, Rubinson L, Vanderschuren A, Hajek J, Murthy S, Ferri M, Crozier I, Ibrahima E, Lamah MC, Schieffelin JS, Brett-Major D, Bausch DG, Shindo N, Chan AK, O'Dempsey T, Mishra S, Jacobs M, Dickson S, Lyon GM, Fowler RA. Ebola virus disease and critical illness. Critical Care. 2016; 20: 217-241
- Rubinson L, Hanfling D, Corey A. Estimation of time period for effective human inhalational anthrax treatment including antitoxin therapy. PLOS Currents Outbreaks 2017.
- Losonczy L, Scalea T, Menaker J, Tran Q, O’Connor J, Andersen B, Dinardo T, Doyle K, Stein D, Tisherman S, Rubinson L. The Critical Care Resuscitation Unit: A new paradigm for optimizing inter-hospital transfer of patients with non-trauma time sensitive critical conditions. ICU Management and Practice. 2018. 1: 56-60.